The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome
Open accessAbstract
In the last decades, the extension of life expectancy and the increased consumption of foods rich in saturated fats and added sugars have exposed the general population to emerging health problems. The prevalence of metabolic syndrome (MS), composed of a cluster of factors as obesity, dyslipidemia, hyperglycemia, and hypertension, is rapidly increasing in industrialized and developing countries leading to precocious onset of age-related diseases. Indeed, oxidative stress, accumulation of advanced glycation endproducts, and a chronic low-grade inflammation are common features of MS and physiological ageing. In particular, the entire set of MS factors contributes to the development of an inflammatory status named metaflammation, which has been associated with activation of early innate immune response through the assembling of the multiprotein complex inflammasome. The most investigated family of inflammasome platforms is the NOD-like receptor pyridine containing (NLRP) 3, which is activated by several exogenous and endogenous stimuli, leading to the sequential cleavage of caspase-1 and IL-1β, followed by secretion of active IL-1β. We here collect the most recent findings on NLRP3 activation in MS providing evidence of its central role in disease progression and organ dysfunction in target tissues of metaflammation, in particular in cardiovascular, hepatic and renal complications, with a focus on oxidative stress and advanced glycation endproducts. A wide overview of the most promising strategies for the modulation of NLRP3 activation and related metabolic repercussions is also provided, since the finding of specific pharmacological tools is an urgent requirement to reduce the social and economic burden of MS- and elderly-associated diseases.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The text we found for this paper looks like another document, so the self-check wasn’t run.
Citations
Cites
2 retracted
Targeting the NLRP3 inflammasome to Reduce Diet-induced Metabolic Abnormalities in Mice
Chiazza, F., Couturier-Maillard, A., Benetti, E., Mastrocola, R., Nigro, D., Cutrìn, J. C., Serpe, L., Aragno, M., Fantozzi, R., Ryffel, B., et al. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00104 · Cited by 86 · cited 10×
“Around 10–20% patients with NAFLD will eventually develop NASH [71], which has been predicted to be the leading indication for liver transplantation in the USA by the year 2020 [72].”
BackgroundInfluentialSelf-citationRetractedMcRae, S., Iqbal, J., Sarkar-Dutta, M., Lane, S., Nagaraj, A., Ali, N., & Waris, G. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.694059 · Cited by 60 · cited 1×
“[81-83] and a reciprocal activation between SREBP and NLRP3 is reported in liver with hepatitis C infection [84].”
BackgroundRetractedInflammation and metabolic disorders
Hotamisligil, G. S. (2006) · Nature · doi:10.1038/nature05485 · Cited by 9,199 · cited 1×
“been coined to define a low-grade, chronic inflammation orchestrated by metabolic cells in response to excess nutrients and energy in metabolic tissues including adipose, liver, muscle, pancreas, and brain [15].”
BackgroundPattern Recognition Receptors and Inflammation
Takeuchi, O., & Akira, S. (2010) · Cell · doi:10.1016/j.cell.2010.01.022 · Cited by 8,895
A role for mitochondria in nlrp3 inflammasome activation
Zhou, R., Yazdi, A. S., Menu, P., & Tschopp, J. (2011) · Nature · doi:10.1038/nature09663 · Cited by 5,602
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Hornung, V., Bauernfeind, F., Halle, A., Samstad, E. O., Kono, H., Rock, K. L., Fitzgerald, K. A., & Latz, E. (2008) · Nature Immunology · doi:10.1038/ni.1631 · Cited by 3,065
Sterile inflammation: sensing and reacting to damage
Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · cited 1×
“gout) drive sterile inflammation through the activation of inflammasome [26-29].”
BackgroundMechanisms linking obesity with cardiovascular disease
Van Gaal, L. F., Mertens, I. L., & De Block, C. E. (2006) · Nature · doi:10.1038/nature05487 · Cited by 2,814 · cited 1×
“Altogether, these factors not only affect body weight homeostasis, but might lead to increased oxidative stress, endothelial dysfunction and vascular inflammation [20].”
BackgroundNonalcoholic Fatty Liver, Steatohepatitis, and the Metabolic Syndrome
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., Natale, S., Vanni, E., Villanova, N., Melchionda, N., et al. (2003) · Hepatology · doi:10.1053/jhep.2003.50161 · Cited by 2,679 · cited 1×
“2 Liver: NLRP3 inflammasome in steatohepatitis, an overview The typical hepatic outcome of MS and over-nutrition is the nonalcoholic fatty liver disease (NAFLD), where the increasing deposition of intracellular lipids may evolve in steatohepatitis (NASH) and fibrosis [69].”
Background
Cited by
The potential mechanism of postoperative cognitive dysfunction in older people
Lin, X., Chen, Y., Zhang, P., Chen, G., Zhou, Y., & Yu, X. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2019.110791 · Cited by 320
Monounsaturated Fatty Acids in Obesity-Related Inflammation
Ravaut, G., Légiot, A., Bergeron, K.-F., & Mounier, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms22010330 · Cited by 249
“volved in several diseases associated with chronic and low-grade inflammation [38,39].”
BackgroundDavidson, S. M., Adameová, A., Barile, L., Cabrera‐Fuentes, H. A., Lazou, A., Pagliaro, P., Stensløkken, K., Garcia‐Dorado, D., & (CA16225), T. E. C. A. (2020) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.15127 · Cited by 204
“Therefore, it is possible that some concomitant modifications of protective pathways may explain discordant results.(116)”
ResultSelf-citationConnecting aging biology and inflammation in the omics era
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022) · Journal of Clinical Investigation · doi:10.1172/jci158448 · Cited by 189
NLRP3 inflammasome activation in inflammaging
Latz, E., & Duewell, P. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.09.001 · Cited by 174
Metadata
- Authors
- Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P.
- Affiliations
- University of Turin (IT)
- Corresponding author
- Collino, Massimo
- ORCID
- Venue
- Current Medicinal Chemistry
- Publisher
- Bentham Science Publishers Ltd.
- Published
- 2018-04-17
- Volume
- 25
- Issue
- 11
- Pages
- 1294-1310
- ISSN
- 0929-8673 (ISSN-L)
- OpenAlex
- W2607038632
- Cited by
- 76
- References
- 101
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 8 · 2023: 8 · 2022: 9 · 2021: 10 · 2020: 14 · 2019: 5 · 2018: 5
- FWCI
- 2.79
- Type
- journal article
- Language
- en
- Open access
- green
- hdl.handle.net
- Licence
- other-oa
- Locations
- Current Medicinal Chemistry (publishedVersion)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Keywords
- metabolic inflammation, NLRP3 inflammasome, metabolic syndrome, IL-1β, caspase-1, oxidative stress, advanced glycation end products, low-grade inflammation, cardiovascular complications, hepatic complications, renal complications, obesity, aging
- MeSH terms
- NLR Family, Pyrin Domain-Containing 3 Protein, Diabetic Nephropathies, Fatty Liver, Humans, Inflammation, Myocardial Reperfusion Injury, Metabolic Syndrome, Inflammasomes
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome. https://app.cochat.ai/papers/10.2174/0929867324666170407123522
- The paper
- Mastrocola, R., Aragno, M., Alloatti, G., Collino, M., Penna, C., & Pagliaro, P. (2018). Metaflammation: Tissue-Specific Alterations of the NLRP3 Inflammasome Platform in Metabolic Syndrome. Current Medicinal Chemistry. https://doi.org/10.2174/0929867324666170407123522
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.